| PERIOD ENDING | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | 28-Sep-08 | | Total Revenue | 2,754,000 | 2,455,000 | 2,517,000 | 3,334,000 | | Cost of Revenue | 864,000 | 738,000 | 755,000 | 921,000 | | | Gross Profit | 1,890,000 | 1,717,000 | 1,762,000 | 2,413,000 | | | Operating Expenses | | Research Development | 619,000 | 603,000 | 604,000 | 621,000 | | Selling General and Administrative | 376,000 | 376,000 | 413,000 | 456,000 | | Non Recurring |
-
| 748,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 895,000 | (10,000) | 745,000 | 1,336,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 89,000 | (91,000) | (294,000) | (223,000) | | Earnings Before Interest And Taxes | 984,000 | (101,000) | 451,000 | 1,113,000 | | Interest Expense |
-
|
-
|
-
| 5,000 | | Income Before Tax | 984,000 | (101,000) | 451,000 | 1,108,000 | | Income Tax Expense | 246,000 | 188,000 | 110,000 | 230,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 738,000 | (289,000) | 341,000 | 878,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 738,000 | (289,000) | 341,000 | 878,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $738,000 | ($289,000) | $341,000 | $878,000 |
|
0.17% Nasdaq 0.00%
Income Statement
